WO2016024875A1 - Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis - Google Patents
Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis Download PDFInfo
- Publication number
- WO2016024875A1 WO2016024875A1 PCT/PL2015/000129 PL2015000129W WO2016024875A1 WO 2016024875 A1 WO2016024875 A1 WO 2016024875A1 PL 2015000129 W PL2015000129 W PL 2015000129W WO 2016024875 A1 WO2016024875 A1 WO 2016024875A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- oil
- psoriasis
- manuka
- cosmetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Definitions
- Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis
- Cosmetic and/or pharmaceutical formulation soothing psoriasis symptoms is the subject of invention.
- Known substances for psoriasis treatment are based on cortycosteroids, combination of cortykosteroids and also combination of antibiotics and salicylans.
- Usa patent no, 3934013 describes anti-inflammatory remedy that consist of cortycosteroids. It is being made by dissolving at least two cortycosteroids in pharmaceutical solvent and after mixing it with proper pharmaceutical substances it creates substance that contains 0,001 - 0,5% of cortycosteroids. From polish patent no. 152379 a method of receiving medication for psoriasis which is based on two cortycosteroids in proportion 1:1 is known. Additionally it consists of salicylic acid and gentamycin. Usa patent no.
- glycosides compounds from different types of marigold Calendula officinalis and its usage as cytostatic substances that help especially in psoriairs treatment.
- Glycosides have cytostatic effect on cells.
- Those remedies do not improve condition of skin with psoriasis, they only reduce the feeling of tension, in most cases they cause side effects like excessive dryness, skin burns, allergic reactions, Immunization of skin to any other remedy. These substances are hard to wash off the skin, what has a big, negative impact if psoriasis is located for example on head's skin.
- Cosmetic and/or pharmaceutical formulation soothing psoriasis symptoms according to invention was based on usage of solely natural active ingredients, cream base consists of 30 emulsifier, thickener, preservative and consists in 100% parts by weight: 0,3-20 part by weight of one or mixture of: linen seed oil, shea oil, cotton seed oil, 03- 25 part by weight of one from: Manuka honey or Manuka leaf extract or Manuka milk or Manuka leaf essentia!
- oil 0,3-20 part by weight of one from: sweet aimond oil or macadamia nut oil, 0,01-10 part by weight of panthenol, 0,01-10 part by weight of vitamin E, 0,01-10 part by weight of glycerin, 0,01-5 part by weight of jasmine essential oil or eukaliptus oil, 0,01-5 part by weight of cedar essential oil.
- Cream designed by the above formula has consistency of light emulsion O/W ⁇ oil in water) with soothing skin with psoriasis properties.
- Cream base we can receive cream, balm, miik or fluid.
- composition of active ingredients can be hanged in base that consists of surfactants, water, thickener, emulsifier and preservative. It creates hair shampoo or body wash. Innovation is described in following applications.
- Cosmetic reduces skin redness and irritation, slows down growth of a us shell, reduces itching. It enhances quality of everyday living for people with psoriasis disease. Cream is easily absorbed into skin, making regular dosage easy. Cosmetic reduces most of inconveniences for people with psoriasis disease. In case of redness of a skin it causes it to fade. Skin of people with psoriasis is irritated and dry. Formulation 120 reduced any type of irritation and moistens skin reducing the feeling of discomfort that accompanies dry skin, if s braking, pouring.
Abstract
Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis that can be part of a facial or body cream, fluid, balm or milk. The formulation consist of mixture of natural oils, essential oils, some kind of extract of Manuka plant for example Manuka Honey and vitamins. The formulation eliminates symptoms that accompany psoriasis like skin's irritation, red spots and scales on a skin, reduces itching.
Description
Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis
DESCRITPION
Cosmetic and/or pharmaceutical formulation soothing psoriasis symptoms is the subject of invention.
There are cosmetics on the market designated to soothe symptoms of psoriasis that contain ichtyol, salicylic acid, steroids, hemp oil, a!lantoin, pine tar, cignolinum.
Known substances for psoriasis treatment are based on cortycosteroids, combination of cortykosteroids and also combination of antibiotics and salicylans. Usa patent no, 3934013 describes anti-inflammatory remedy that consist of cortycosteroids. It is being made by dissolving at least two cortycosteroids in pharmaceutical solvent and after mixing it with proper pharmaceutical substances it creates substance that contains 0,001 - 0,5% of cortycosteroids. From polish patent no. 152379 a method of receiving medication for psoriasis which is based on two cortycosteroids in proportion 1:1 is known. Additionally it consists of salicylic acid and gentamycin. Usa patent no. 6225342 (PCT/GB96/01792) describes application of glycosides compounds from different types of marigold Calendula officinalis and its usage as cytostatic substances that help especially in psoriairs treatment. Glycosides have cytostatic effect on cells.
Those remedies do not improve condition of skin with psoriasis, they only reduce the feeling of tension, in most cases they cause side effects like excessive dryness, skin burns, allergic reactions, Immunization of skin to any other remedy. These substances are hard to wash off the skin, what has a big, negative impact if psoriasis is located for example on head's skin. Cosmetic and/or pharmaceutical formulation soothing psoriasis symptoms according to invention was based on usage of solely natural active ingredients, cream base consists of 30 emulsifier, thickener, preservative and consists in 100% parts by weight: 0,3-20 part by weight of one or mixture of: linen seed oil, shea oil, cotton seed oil, 03- 25 part by weight of one from: Manuka honey or Manuka leaf extract or Manuka milk or Manuka leaf essentia! oil, 0,3-20 part by weight of one from: sweet aimond oil or macadamia nut oil, 0,01-10 part by weight of panthenol, 0,01-10 part by weight of vitamin E, 0,01-10 part by weight of glycerin, 0,01-5 part by weight of jasmine essential oil or eukaliptus oil, 0,01-5 part by weight of cedar essential oil.
Cream designed by the above formula has consistency of light emulsion O/W {oil in water) with soothing skin with psoriasis properties. Depending on composition of cream base we can receive cream, balm, miik or fluid.
The same composition of active ingredients can be hanged in base that consists of surfactants, water, thickener, emulsifier and preservative. It creates hair shampoo or body wash.
Innovation is described in following applications. Example 1 - body cream
Cetyl alcohol 2%
Olivem 1000 emuisifier 7%
Water 68%
Phenoxyethanol 1%
Glycerin 1%
Linen seed oil 3%
Manuka milk 12%
Cotton seed oil 3%
Panthenol 2%
Vitamin E 0,96%
jasmine essential oil 0,02%
Cedar essential oii 0,02% Example 2 - face cream
Cetearyl alcohol 2%
BTMS emuisifier 5% Water 79,97%
Phenoxyethanol 1%
Panthenol 2%
Shea oii 3%
Manuka essential oil 0,03%
Sweet almond oil 4%
Vitamin E 0,98%
Glycerin 2%
Eukaliptus essential oii 0,01%
Cedar essential oil 0,01%
95 Example 3 - hair shampoo
Water 47,1%
Guar gum 0,9%
BTMS emulsifier 4%
loo Coco betaine 12%
Coco glucoside 30%
Citric acid Q.S.
Shea oil 2,75%
Phenoxyethanoi 1%
105 jasmine essential oil 0,01%
Cedar essential oil 0,01%
Manuka essential oil 0,03%
Macadamia nut oil 0,7%
Panthenol 0,5%
no Vitamin E 0,5%
Glycerin 0,5%
Cosmetic reduces skin redness and irritation, slows down growth of a us shell, reduces itching. It enhances quality of everyday living for people with psoriasis disease. Cream is easily absorbed into skin, making regular dosage easy. Cosmetic reduces most of inconveniences for people with psoriasis disease. In case of redness of a skin it causes it to fade. Skin of people with psoriasis is irritated and dry. Formulation 120 reduced any type of irritation and moistens skin reducing the feeling of discomfort that accompanies dry skin, if s braking, pouring.
Next advantage of cream is the fact that after application it is absorbed by skin immediately and it does not leave a fat mask on skin.
It makes it possible to apply cream any time of day not being concerned about clothes getting dirty and without unwanted
esthetic effects.
For people with psoriasis located on the skin of their head it is
130 incredibly advantage that cream is easily removed from skin. During application it is impossible to avoid greasing the hair. Substance according to innovation is easy to wash off without need to apply additional substances like eggs yolk, very hot water, washing hair repeatably. To clean the hair person can use regular shampoo and
135 standard one or two times washing the hair, which makes the hair condition not damaged and hair stay healthy and shining, itching in people with psoriasis disease is being reduced after regular application of cosmetic, in most cases irrevocably. All described advantages of cosmetic cause radical increase in life comfort for people with psoriasis
140 disease. Eliminating annoying symptoms that accompany psoriasis like skin's irritation, non esthetic red spots and scales on a skin,
especially on parts uncovered by clothing (face, hands, and in summer whole body) increases psychological comfort. People which used to avoid social encounters, avoiding public places like swimming poois,
145 hairdresser etc. After treatment change they behavior radically and become much more active.
Claims
CLAIM
Cosmetic and/or pharmaceutical formulation soothing psoriasis symptoms in which cream base consists of emulsifier, thickener, preservative is telling that consists in 100% parts by weight: 0,3-20 part by weight of one or mixture of: linen seed oil, shea oil, cotton seed oil
03-25 part by weight of one from: Manuka honey or Manuka leaf extract or Manuka milk or Manuka leaf essential oil
0,3-20 part by weight of one from: sweet almond oil or macadamia nut oil
0,01-10 part by weight of panthenoi
0,01-10 part by weight of vitamin E 0,01-10 part by weight of glycerin 0,01-5 part by weight of jasmine essential oil or eukaiiptus oil
0,01-5 part by weight of cedar essential oil
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL409156A PL409156A1 (en) | 2014-08-11 | 2014-08-11 | Cosmetic and/or pharmaceutical composition having soothing effect on the psoriasis symptoms |
| PLP.409156 | 2014-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2016024875A1 true WO2016024875A1 (en) | 2016-02-18 |
Family
ID=54148605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/PL2015/000129 WO2016024875A1 (en) | 2014-08-11 | 2015-08-11 | Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis |
Country Status (2)
| Country | Link |
|---|---|
| PL (1) | PL409156A1 (en) |
| WO (1) | WO2016024875A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018117869A1 (en) * | 2016-12-23 | 2018-06-28 | Mm Health Ltd | Topical formulation comprising green lipped mussel and honey |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3934013A (en) | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
| PL152379B1 (en) | 1986-02-14 | 1990-12-31 | Procedure for obtaining the preparation for the treatment of the disease psoriasis: drug for the treatment of psoriasis and its application | |
| CA2120967A1 (en) * | 1994-04-11 | 1995-10-12 | Boubaker Boussetta | Medicine for the treatment of psoriasis and skin diseases |
| US6225342B1 (en) | 1995-07-25 | 2001-05-01 | University Of Strathclyde | Use of calendula glycosides for the treatment of psoriasis |
| US6403654B1 (en) * | 2000-04-13 | 2002-06-11 | Mariana De Oliveira | Compositions for and method of treatment for psoriasis |
| EP1520577A1 (en) * | 2003-09-30 | 2005-04-06 | Kneipp-Werke Kneipp-Mittel-Zentrale GmbH & CO. KG | Cosmetic or dermatological composition comprising oil of evening primrose |
| US20050100524A1 (en) * | 2003-11-10 | 2005-05-12 | Springstead Patricia R. | Skin formulation |
-
2014
- 2014-08-11 PL PL409156A patent/PL409156A1/en unknown
-
2015
- 2015-08-11 WO PCT/PL2015/000129 patent/WO2016024875A1/en active Application Filing
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3934013A (en) | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
| PL152379B1 (en) | 1986-02-14 | 1990-12-31 | Procedure for obtaining the preparation for the treatment of the disease psoriasis: drug for the treatment of psoriasis and its application | |
| CA2120967A1 (en) * | 1994-04-11 | 1995-10-12 | Boubaker Boussetta | Medicine for the treatment of psoriasis and skin diseases |
| US6225342B1 (en) | 1995-07-25 | 2001-05-01 | University Of Strathclyde | Use of calendula glycosides for the treatment of psoriasis |
| US6403654B1 (en) * | 2000-04-13 | 2002-06-11 | Mariana De Oliveira | Compositions for and method of treatment for psoriasis |
| EP1520577A1 (en) * | 2003-09-30 | 2005-04-06 | Kneipp-Werke Kneipp-Mittel-Zentrale GmbH & CO. KG | Cosmetic or dermatological composition comprising oil of evening primrose |
| US20050100524A1 (en) * | 2003-11-10 | 2005-05-12 | Springstead Patricia R. | Skin formulation |
Non-Patent Citations (2)
| Title |
|---|
| BENSOUILAH J: "Psoriasis and aromatherapy", INTERNATIONAL JOURNAL OF AROMATHERAPY, AROMATHERAPY PUBLICATIONS, HOVE, GB, vol. 13, no. 1, 1 January 2003 (2003-01-01), pages 2 - 8, XP009122124, ISSN: 0962-4562, DOI: 10.1016/S0962-4562(03)00036-5 * |
| KISSELL J: "Honey as medicine. Sweet relief", INTERNET CITATION, 17 June 2004 (2004-06-17), pages 1 - 3, XP002564311, Retrieved from the Internet <URL:http://itotd.com/articles/218/honey-as-medicine> [retrieved on 20100108] * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018117869A1 (en) * | 2016-12-23 | 2018-06-28 | Mm Health Ltd | Topical formulation comprising green lipped mussel and honey |
Also Published As
| Publication number | Publication date |
|---|---|
| PL409156A1 (en) | 2016-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520051B (en) | Hair and body shampoo | |
| KR101011191B1 (en) | A shampoo composite and making method thereof | |
| CN105902418A (en) | Imitated sebum matrix, external preparation including imitated sebum matrix and application thereof | |
| KR20200113600A (en) | Composition for hairloss and scalp care | |
| CA2327003A1 (en) | Process for making phytocosmetic and phytodermatological external skin care products | |
| US10420962B2 (en) | Organic hair formulation and treatment | |
| US10111827B2 (en) | Hair loss prevention and restoration solution | |
| JP2006321758A (en) | Cosmetic | |
| JP2001233723A (en) | Cosmetic set for mind and body | |
| Gholve et al. | Formulation and evaluation of polyherbal antidandruff powder shampoo | |
| WO2016024875A1 (en) | Cosmetic and/or pharmaceutical formulation soothing symptoms of psoriasis | |
| JPH0853327A (en) | Hair tonic composed of allantoin or its derivative | |
| CN104473799B (en) | A kind of pseudo-ginseng shower cream and preparation method thereof | |
| CN105997645A (en) | Multi-moisturizing makeup removing lotion and preparation method thereof | |
| Kala et al. | Formulation and invitro evaluation of poly herbal anti aging face cream | |
| RU2793183C1 (en) | Composition for hair care, method for its preparation and method for application of infusion for hair care | |
| RU2799443C2 (en) | Hair and scalp cleaner and care | |
| ES2698702B2 (en) | COMPOSITION FOR SKIN, HAIR AND LEATHER CARE CARE | |
| RU2755199C1 (en) | Washing foam | |
| Fatima et al. | An Insight into Animal and Plant Halal Ingredients used in Cosmetics | |
| JP3170540U (en) | Cosmetics containing sedan grass | |
| Krishnan et al. | FORMULATION AND EVALUTION OF HERBAL VANISHING CREAM | |
| Thomas et al. | Hair is an accoutrement, hair is jewelry, it’s an accessory-Realize “The killing effects of shampoo” | |
| RU2611347C1 (en) | Personal hygiene agent with acaricidal activity on mite demodex | |
| Chavda et al. | Cosmetic toxicity and Natural solutions for Personal Care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15766670 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 15766670 Country of ref document: EP Kind code of ref document: A1 |